The ENABLE trial, conducted in rural regions of Vermont and New Hampshire, reports a positive impact on the 1-year survival of advanced cancer patients. A parallel study, ENABLE III, reported benefits to caregivers following early introduction of palliative care in these advanced cancer patients.
Early concurrent palliative care (PC) in patients with advanced cancer had a significantly beneficial effect on 1-year survival, even for patients living in a remote rural setting, according to results from the ENABLE trial. The 1-year survival rate was 63% for those who received early PC compared with 48% in the group that received delayed care (15% difference, P = .038), reported J. Nicholas Dionne-Odom, PhD, of the University of Alabama in Birmingham, and colleagues.
Most of the patients lived in rural New Hampshire or Vermont, making ENABLE "the only feasible and effective telehealth early [palliative care] model for patients with advanced cancer and family caregivers in a rural setting," the authors wrote in the Journal of Clinical Oncology.
Link to the report on Medpage Today:
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen